Trius Therapeutics Inc

CIK 1356857 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Trius Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Feb 14, 2014SC 13G/A0001144204-14-009622
Oct 10, 2013CT ORDER9999999997-13-015554
Sep 23, 201315-12B0001104659-13-071544
Sep 16, 2013EFFECT9999999995-13-002670
Sep 16, 2013EFFECT9999999995-13-002671
Sep 11, 2013SC 14D9/A0001104659-13-069286
Sep 11, 20138-K0001104659-13-069285
Sep 11, 2013SC TO-T/A0001104659-13-069283
Sep 11, 201325-NSE0001354457-13-000183
Sep 5, 2013SC 14D9/A0001104659-13-068238
Sep 5, 2013SC TO-T/A0001104659-13-068235
Sep 3, 2013SC TO-T/A0001104659-13-067763
Aug 29, 2013SC TO-T/A0001104659-13-067058
Aug 29, 2013SC 14D9/A0001104659-13-067059
Aug 26, 2013SC 13D/A0001193125-13-346431
Aug 15, 2013SC TO-T/A0001104659-13-064301
Aug 13, 2013SC 14D90001047469-13-008399
Aug 13, 2013SC TO-T0001047469-13-008396
Aug 9, 2013SC 13D0001104659-13-062317
Aug 7, 201310-Q0001193125-13-324372
Aug 6, 20138-K0001193125-13-321549
Aug 2, 2013SC TO-C0001104659-13-059256
Aug 1, 2013SC TO-C0001104659-13-058828
Aug 1, 2013SC TO-C0001104659-13-058807
Aug 1, 20138-K0001193125-13-313330